SFO
CL icon

Stokes Family Office’s Colgate-Palmolive CL Stock Holding History

Stokes Family Office’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Sell
2,428
-780
-24% -$69.5K 0.02% 267
2025
Q4 		$253K Buy
+3,208
New +$252K 0.02% 268
2023
Q4 		– Sell
-5,071
Closed -$361K – 241
2023
Q3 		$361K Sell
5,071
-289
-5% -$21.6K 0.04% 216
2023
Q2 		$413K Buy
5,360
+559
+12% +$43.3K 0.05% 202
2023
Q1 		$361K Sell
4,801
-215
-4% -$16K 0.05% 202
2022
Q4 		$395K Buy
5,016
+2,111
+73% +$158K 0.05% 187
2022
Q3 		$204K Sell
2,905
-355
-11% -$27.8K 0.03% 251
2022
Q2 		$261K Buy
3,260
+567
+21% +$44.3K 0.04% 224
2022
Q1 		$204K Sell
2,693
-1,464
-35% -$116K 0.03% 243
2021
Q4 		$355K Buy
4,157
+1,111
+36% +$86.8K 0.04% 175
2021
Q3 		$230K Sell
3,046
-2,489
-45% -$198K 0.03% 205
2021
Q2 		$450K Buy
5,535
+1,046
+23% +$85.5K 0.06% 149
2021
Q1 		$354K Sell
4,489
-875
-16% -$68.6K 0.06% 155
2020
Q4 		$459K Buy
5,364
+2,091
+64% +$173K 0.09% 115
2020
Q3 		$252K Buy
+3,273
New +$250K 0.06% 133

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stokes Family Office's CL Position: Q1 2026 in Review

Stokes Family Office reduced its Colgate-Palmolive (CL) stake by 24% in Q1 2026, selling an estimated $69.5K and leaving 2,428 shares worth $207K. The position accounts for 0.02% of the portfolio, ranked #267.

Stokes Family Office first reported a position in CL in Q3 2020 and has held it in 15 quarters since. The position peaked at $459K in Q4 2020. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Stokes Family Office held 2,428 shares of Colgate-Palmolive worth $207K as of Q1 2026.
  • Stokes Family Office sold 780 Colgate-Palmolive shares in Q1 2026, an estimated $69.5K.
  • Colgate-Palmolive made up 0.02% of Stokes Family Office's portfolio in Q1 2026, its #267 holding.
  • Stokes Family Office first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 15 quarters since.
  • Stokes Family Office's Colgate-Palmolive position peaked at $459K in Q4 2020.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.